Poly(ε-caprolactone)

Poly(ε-caprolactone) (PCL) Recent Market Intelligence Report

I. Price Dynamics
- Current Price: As of April 30, 2026, the domestic standard-grade PCL market price in China remains stable at RMB 53,000 per metric ton, unchanged from the beginning of the year and at the upper end of the past 12-month range.
- Import Price: Premium medical-grade PCL is priced at RMB 8.00 per gram (approximately RMB 80,000 per metric ton), reflecting strong market demand for high-purity, customized products.
- Historical Volatility: In January 2026, the market price ranged between RMB 32,000–38,000 per metric ton—lower than the RMB 35,000–45,000/ton oscillation range observed from 2023 to 2025—primarily driven by improved supply-demand balance and declining raw material costs.

II. Supply-Demand Dynamics
- Capacity Expansion: China’s PCL production capacity exceeded 50,000 metric tons/year in 2025; over 40,000 tons of new capacity is planned for 2026, concentrated in the East and South China regions, while Southwest China is developing a differentiated layout leveraging its green energy infrastructure.
- Production & Consumption: Actual output reached 39,000 metric tons by end-2025, with apparent consumption at 42,000 metric tons. Import dependency stands at approximately 12%, predominantly for high-purity medical-grade products.
- Regional Distribution: The East China region accounts for 58% of national capacity; South China holds 22.9%; North China and Southwest China account for 10.4% and 8.3%, respectively.

III. Raw Material Market
- Domestication Rate Improvement: The domestic production rate of ε-caprolactone (CL) is projected to rise from under 30% in 2025 to over 50% in 2026. Companies including Wanhua Chemical and Hualu Hengsheng are accelerating CL project deployment, reducing PCL production costs by 15–20%.
- Raw Material Price: As of late November 2025, cyclohexanone prices in China stood at RMB 6,575 per metric ton—a 27.88% year-on-year decline—further compressing PCL raw material costs.

IV. Application Sectors
- Medical Field: The 2024 market size reached RMB 1.488 billion, up 8.22% year-on-year, representing ~45% of total PCL demand. Demand continues to grow for absorbable sutures, drug delivery carriers, and tissue engineering scaffolds; the rising adoption of minimally invasive surgery is boosting the share of premium products.
- Eco-Friendly Packaging: Policy-mandated replacement of conventional plastics has elevated PCL-based composite penetration in frozen food packaging and courier bags to over 20%. The mandatory National Standard for Green Express Packaging, effective December 2025, requires ≥35% biodegradable materials in cold-chain packaging for fresh e-commerce logistics. PCL—due to its low-temperature resistance and superior puncture resistance—is currently the only commercially viable biodegradable base material meeting full cold-chain temperature-control requirements.
- 3D Printing: Demand for medical-grade PCL grows at ~30% annually; emerging applications—including flexible electronics and self-healing coatings—are progressing toward commercialization.
- Import Dependency: Despite expanding domestic capacity, high-end medical-grade PCL remains partially import-dependent, with domestic production share still below 60%.

V. Policy Environment
- Policy Support: China’s “Dual Carbon” strategy and the “14th Five-Year Plan for Bioeconomic Development” explicitly support biodegradable materials such as PCL. Multiple provincial governments have introduced special subsidies and tax incentives.
- Industry Standards: The 2018 “General Technical Requirements for Biodegradable Plastics” establishes clear technical specifications for PCL production, testing, and application, providing regulatory guidance for the sector.

Analysis & Assessment

I. Factors Supporting Price Stability
- Cost Reduction: Increased domestic CL production and falling cyclohexanone prices effectively lower PCL manufacturing costs, supporting price stability.
- Balanced Supply-Demand: Gradual ramp-up of new capacity coincides with sustained growth in high-end demand (e.g., medical and eco-packaging), narrowing supply gaps and sustaining elevated pricing.

II. Accelerating Import Substitution
- Domestic Technological Breakthroughs: Hunan Juren New Materials operates the world’s largest single-line 50,000-ton/year caprolactone production facility; Shenzhen Guanghua Weiye has developed the world’s only continuous PCL polymerization technology—both breaking long-standing foreign technological monopolies and enhancing competitiveness of high-end domestic products.
- Policy Catalysts: The National Medical Products Administration (NMPA) included PCL in its “Guidance Principles for Absorbable Medical Device Polymers”, leading to a 47% year-on-year increase in Class III medical device registration submissions—accelerating import substitution.

III. Trend Toward High-End Differentiation
- Medical Applications: Population aging and expanding minimally invasive surgery drive demand for premium PCL products—including bone repair scaffolds and long-acting sustained-release microspheres.
- Industrial Applications: PCL-based adhesives and insulating materials are gaining traction in 5G base stations and battery components for new-energy vehicles—fueling value-added product upgrades.

Future Outlook

I. Price Trends
- Commodity-Grade PCL: Economies of scale and technological advancement are expected to drive prices down to RMB 25,000–30,000 per metric ton.
- Medical-Grade PCL: Price divergence will intensify; customized, ultra-high-purity products will maintain significant premiums.

II. Market Size Forecast
- Overall Market: Expected to reach RMB 5.8 billion by 2030, growing at a CAGR exceeding 25%.
- Application Mix: Medical applications’ share will rise to >40%; eco-packaging will stabilize around 35%; 3D printing consumables will expand to ~15%.

III. Industry Trends
- Vertical Integration: Enterprises are shifting from isolated upstream raw material production to integrated operations spanning CL synthesis → PCL polymerization → downstream applications—enhancing profitability and supply chain resilience.
- Global Competition: With breakthrough technologies and expanded capacity, domestic players are progressively replacing BASF, Covestro, and other international giants in the Chinese market—and advancing toward becoming core global suppliers of biodegradable materials.
- Green & Low-Carbon Transition: PCL production processes are increasingly incorporating green hydrogen and bio-based CL technologies to reduce carbon emissions—aligning with global carbon neutrality goals.